Traduction de «committee of experts on blood » (Néerlandais → Français) :

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

Interdepartmental committee of experts on blood, organs,
Interdepartmental committee of experts on blood, organs,

Interdepartmental committee of experts on blood, organs, ICVV – CICSA cells, tissues and embryos (with FPS Public Health, KCE, RIZIV Influenza (in cooperation with external partners)
Interdepartmental committee of experts on blood, organs, ICVV – CICSA cells, tissues and embryos (with FPS Public Health, KCE, RIZIV Influenza (in cooperation with external partners)

Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:
Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:

Nucleic acid sequence based amplification Nucleic Acid Amplification Testing Non-heart beating donors National Institute for Biological Standards and Control Optische densiteit Occupational Safety and Health Administration Perazijnzuur Phosphate buffered saline Polymerase chain reaction Perazijnzuur ethanol sterilisatie Positive predictive value Positief predictieve waarde Polyvinyl-pyrrolidon Povidone-iodine Quaternaire ammoniumverbindingen Radio-immunoprecipitatie test Ribonucleic acid Ribonuclease H Respiratoir syncytiaal virus Reverse transcriptase Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Median tissue culture infective dose Transcription-mediated amplification Tumor necrosis factor United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Verenigde Staten Werkgroep infectiepreventie West Nile virus World Health Organization
Morbidity and mortalility weekly report Nucleic acid sequence based amplification Nucleic Acid Amplification Testing National Institute for Biological Standards and Control Occupational Safety and Health Administration Phosphate buffered saline ou tampon phosphate Polymerase chain reaction Stérilisation acide peracétique-éthanol Positive predictive value Polyvinyl-pyrrolidon Povidone-iodine Dérivés de l’ammonium quaternaire Ribonuclease H Reverse transcriptase ou transcriptase inverse Advisory Committee on the Safety of Blood, Tissues and Organs Sterility assurance level Severe acute respiratory syndrome Syndrome d’immunodéficience acquise Median tissue culture infective dose Test d’immunofluorescence indirecte Transcription-mediated amplification Tumor necrosis factor Test de radio-immunoprécipitation United Kingdom United Kingdom Blood Transfusion Services Ultraviolet Vapour-phase hydrogen peroxide Valeur prédictive positive Virus respiratoire syncytial Etats-Unis Werkgroep infectiepreventie ou groupe de travail sur la prévention des infections West Nile virus World Health Organization

Lower benchmark dose Contaminants in the food chain Koper European Food Safety Authority Federaal agentschap voor de veiligheid van de voedselketen Ijzer Scientific Institute of Public Health Joint Expert Committee WHO/FAO on Food Additives Lichaamsgewicht Margin of Exposure Nikkel Lood Provisional tolerable weekly intake Toelaatbare dagelijkse inname Toxicologische referentiewaarde World Health Organization Wetenschappelijk Instituut Volksgezondheid Zink
AFSCA Agence fédérale pour la sécurité de la chaîne alimentaire BMDL Lower benchmark dose CONTAM Contaminants in the food chain CSS Conseil Supérieur de la Santé Cu Cuivre DJT Dose journalière tolérable EFSA European Food Safety Authority Fe Fer IPH Scientific Institute of Public Health ISP Institut Scientifique de la Santé Publique JECFA Joint Expert Committee WHO/FAO on Food Additives MoE Margin of Exposure Ni Nickel pc poids corporel Pb Plomb PTWI Provisional tolerable weekly intake VTR Valeur toxicologique de référence WHO World Health Organization Zn Zinc

Study on Bacteria Standards (Transfusion-Relevant Bacterial Strain Panel) and Proposal for a validation study for enlargement of the transfusion-relevant bacterial strain panel. Geneva:WHO-Expert Committee on Biological Standardization; 2010. WHO/BS/10.2154.
Geneva:WHO-Expert Committee on Biological Standardization; 2010. WHO/BS/10.2154.

De link met de activiteiten van het Committee on Herbal Medicinal Products (HMPC) via de voorbereiding van de monografieën door de experts en de opvolging van het dossier betreffende gezondheidsbeweringen.
Le lien avec les activités du Committee on Herbal Medicinal Products (HMPC) via la préparation des monographies par les experts, le suivi du dossier relatif aux allégations de santé.

The Scientific Committee will work with to experts from the various departments and services in the Agency in order to realise these activities.
The Scientific Committee will work with to experts from the various departments and services in the Agency in order to realise these activities.